r="LTR" style="text-align: center;">Pfizer
All over the world, Pfizer colleagues work together to positively impact health for everyone, everywhere. Our colleagues have the opportunity to grow and develop a career that offers both individual and company success; be part of an ownership culture that values diversity and where all colleagues are energized and engaged; and the ability to impact the health and lives of millions of people. Pfizer, a global leader in the bio pharmaceutical industry, is continuously seeking top talent who are inspired by our purpose to innovate to bring therapies to patients that significantly improve their lives.
Job Title: Associate Safety Risk Lead
Job Description:
SRLs perform proactive Safety Surveillance (SS) and Risk Management (RM) to effect product safety signal detection & evaluation, risk assessment and safety risk minimization.
Primary Responsibilities :
- Performs proactive Safety Surveillance (SS) and Risk Management (RM) to effect product safety signal detection, risk assessment and safety risk minimization.
- Colleague capability (see separately available SRL capabilities and responsibilities continuum) will drive Nature and Complexity of Assigned Responsibilities and Activities:
- Safety Risk Leads (SRL) in SSRM may be assigned as the product “safety-management-team” (e.g. Risk Management Committee) Chairs and Asset (Product) Team safety representatives, flexibly supporting all BU/RUs. They will collaborate closely with the relevant WWS Safety Strategy Business Unit/Research Group Heads to support the appropriate BU safety strategies.
- The SRL obtains guidance from the relevant WWS Safety Strategy Business Unit/Research Unit Leads to meet the BU/RU Safety Strategy goals.
- SRLs may be assigned to act as a Safety Point of Contact to the Asset Teams, ensuring a unified communication on safety matters for WSR/WWS.
- Providing and accumulating DA-specific pharmacovigilance expertise, and applying this to various BUs’ products assigned to the SRL operating from a SSRM DA-Cluster. Each SSRM DA-Cluster functions as a “Centre of Excellence”.
- Performing frequent proactive Holistic Safety Review for products, across the span of relevant available safety data information. Reviews are incremental, cumulative and aggregate, to include the body of safety information available from WWS/WSRO and elsewhere (e.g. clinical, epidemiology, spontaneous, literature & regulatory cases, other scientific data).
- Ensuring Consistency of Safety Risk Messaging for a particular product or class of products, across multiple indications/BUs within the many safety reports and communications for that product. Providing suitable summaries of product risks to summary document authors where appropriate, for example providing medical content/B-R statements and overall risk messaging of the safety profile to WSR/SER Authors.
- Performing ad hoc special scholarly SS & RM activities, rapidly, to meet specific needs in the BUs, such as RRT deliverables/emerging safety issue white papers/product Due Diligence Assessments.
- Identifying opportunities for Consistency and Standards for SS & RM approaches and processes within a DA-Cluster and across BUs, and supporting the piloting and implementation of such.
- Innovating, championing and implementing Novel Approaches to SS & RM across BUs: engagement in Continuous Improvement initiatives, Safety Sciences Research & Communications activities, including methodological improvements.
- Platform for additional Centers of Excellence (e.g. Vaccines, Safety Advisory Councils, Contributions to or coordination of Other Pan-BU/RU activities).]
- Engagement in inspection readiness and support. Provision of data to project managers for metrics and activity tracking.
Further;
o Providing SS & RM support for a particular product, across the product’s multiple use in different BUs
o Providing SS & RM support for a particular product in a BU, within and across the product’s multiple indications in a BU
o Leveraging DA focused expertise flexibly into all BUs, and deployment to Due Diligence in-licensing assessments
o Focuses intra- and inter- DA-Cluster sharing of information between related areas (e.g. safety knowledge of Pain vs Inflammation co-prescribing)
o Enables “matrix assignment” from within SSRM to supporting WWS Group Heads.
May work across more than one SSRM DA or DA-Cluster as appropriate to business need. The SRL may support product teams locally or globally (remote).
May be assigned to chair/lead/support various Safety Management Teams (e.g. RMC and RMC CWGs etc.), on one or more products or group of products, for one or more Business Units.
(Note: “BU” used herein = BU/RU).
